CEO Kwon-seon Lee acquires additional 7,053 shares via open market purchase (avg. 6,978 won)
- CEO Kwon-seon Lee acquired additional 7,053 common shares via open market purchases from April 1 to 6, 2026 (average price 6,978 won)
- As of the report date (Apr 7), Lee's stake increased to 3,224,118 shares (34.52%), up 0.08 percentage points from the previous report
- Purchase prices (6,685~7,074 won) were above the current market price (5,970 won), suggesting management's view of undervaluation
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: [Correction of Description] Report on Ownership of Specific Securities, etc. by Executives and Major Shareholders
- Company: Cell Bio Human Tech (318160)
- Submission: Kwon-seon Lee
- Receipt: 05-20-2026